SEC Form 4

FORM 4

[ ] Check this box if no longer
subject to Section 16. Form 4 or Form
5 obligations may continue.
See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940

OMB APPROVAL


OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden
hours per response. . . . . 0.5

1. Name and Address of Reporting Person*
Nicholas, Jr., N.J.     

(Last)                      (First)                      (Middle)
One Boston Scientific Place

(Street)
Natick, MA     01760-1537

(City)                      (State)                      (Zip)
USA

2. Issuer Name and Ticker
    or Trading Symbol

Boston Scientific Corporation   (BSX)

3. I.R.S. Identification
    Number of Reporting
    Person, if an entity
    (voluntary)

4. Statement for
    (Month/Day/Year)

    December 31, 2002

5. If Amendment,
    Date of Original
    (Month/Year)

6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

           X          Director                           10% Owner
                        Officer                             Other

Officer/Other
Description                              

7. Individual or Joint/Group
    Filing (Check Applicable Line)

X   Individual Filing
      Joint/Group Filing

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security
    (Instr. 3)

2. Transaction Date
    (Month/Day/Year)

3. Transaction
    Code
    and
    Voluntary
    Code
    (Instr. 8)

Code  |  V    

4. Securities Acquired (A) or Disposed (D) Of
    (Instr. 3, 4, and 5)



        Amount      |         A/D         |         Price          

5. Amount of
    Securities
    Beneficially
    Owned at
    End ofMonth

    (Instr. 3 and 4)

6. Owner-
    ship
    Form:
    Direct(D)
    or
    Indirect (I)

    (Instr. 4)

7. Nature of
     Indirect
     Beneficial
     Ownership

    (Instr. 4)

Common Stock



60,000

I

By IRA

Common Stock



76,000

I

By Trust

Common Stock



20,000

I

By Trust 2








Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

(over)
SEC 1474 (3-99)

Nicholas, Jr., N.J. - December 2002

Form 4 (continued)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
    (Instr. 3)

2. Conver-
    sion or
    Exercise
    Price of
    Deri-
    vative
    Security

3. Transaction
    Date

    (Month/
    Day/
    Year)

4. Transaction
    Code
    and
    Voluntary (V)
    Code
    (Instr.8)

Code | V    

5. Number of Derivative
    Securities Acquired (A)
    or Disposed (D) Of

    (Instr. 3,4 and 5)

6. Date Exercisable(DE) and
    Expiration Date(ED)
    (Month/Day/Year)





  (DE)     |     (ED)  

7. Title and Amount of
    Underlying Securities
    (Instr. 3 and 4)

8. Price
    of
    Derivative
    Security
    (Instr.5)

9. Number of
    Derivative
    Securities
    Beneficially
    Owned
    at End of
    Month
    (Instr.4)

10.
Owner-
ship
Form of
Deriv-
ative
Security:
Direct
(D)
or
Indirect
(I)

11. Nature of
      Indirect
      Beneficial
      Ownership
      (Instr.4)

Stock Equivalent Units (1)

$0.0000

12/31/2002

   A |     

    (A) 288


Common Stock - 288

$30.3740

9,177

D


Phantom Stock (2)

$0.0000





Common Stock - 4,000


4,000

D


Stock Option (Right to Buy) NED

$20.8750




Varies (3) | 05/10/2006

Common Stock - 4,000


4,000

D


Stock Option (Right to Buy) NED

$24.8125




Varies (4) | 05/05/2007

Common Stock - 4,000


4,000

D


Stock Option (Right to Buy) NED

$36.6875




Varies (5) | 05/05/2008

Common Stock - 4,000


4,000

D


Stock Option (Right to Buy) NED

$41.2500




Varies (6) | 05/04/2009

Common Stock - 4,000


4,000

D


Stock Option (Right to Buy) NED

$28.3125




Varies (7) | 05/09/2010

Common Stock - 4,000


4,000

D


Stock Option (Right to Buy) NED

$15.5300




Varies (8) | 05/08/2011

Common Stock - 2,000


2,000

D


Stock Option (Right to Buy) NED

$24.6800




Varies (9) | 05/07/2012

Common Stock - 2,000


2,000

D













Explanation of Responses :

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
        See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:   File three copies of this Form, one of which must be manually signed. If space is insufficient,
            See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not
required to respond unless the form displays a currently valid OMB number.

By: /s/ Lawrence J. Knopf, Attorney-in-fact
________________________________            01-03-2003    
** Signature of Reporting Person                         Date

N.J. Nicholas, Jr.

Page 2
SEC 1474 (3-99)

Nicholas, Jr., N.J. - December 2002

Form 4 (continued)

FOOTNOTE Descriptions for Boston Scientific Corporation (BSX)

Form 4 - December 2002

N.J. Nicholas, Jr.
One Boston Scientific Place

Natick, MA 01760-1537

Explanation of responses:

(1)   Stock equivalent units were acquired by the Reporting Person pursuant to the Boston Scientific Corporation Deferred Compensation Program.
(2)   Restricted stock granted to reported person and deferred under the Company's Deferred Compensation Program.
(3)   Grant to reporting person of options to buy 4,000 shares of Common Stock exercisable in annual installments of 1,333 shares on May 10, 1997, 1,333 shares on May 10, 1998 and 1,334 shares on May 10, 1999, the anniversary date of the grant.
(4)   Grant to the reporting person of options to buy 4,000 shares of Common Stock exercisable in annual installments of 1,333 shares on May 5, 1998, 1,333 shares on May 5, 1999 and 1,334 shares on May 5, 2000.
(5)   Grant to the reporting person of options to buy 4,000 shares of Common Stock exercisable in annual installments of 1,333 shares on May 5, 1999, 1,333 shares on May 5, 2000 and 1,334 shares on May 5, 2001.
(6)   Grant to the reporting person of options to buy 4,000 shares of Common Stock exercisable in annual increments of 1,333 on May 4, 2000, 1,333 shares on May 4, 2001 and 1,334 shares on May 4, 2002, the anniversary date of the grant.
(7)   Grant to reporting person of options to buy 4,000 shares of Common Stock exercisable in annual installments of 1,333 shares on May 9, 2001, 1,333 shares on May 10, 2002 and 1,334 shares on May 9, 2003, the anniversary date of the grant.
(8)   Grant to the reporting person of options to buy 2,000 shares of Common Stock exercisable in annual installments of 667, 667 and 666 shares each on May 8, 2002, 2003 and 2004, the anniversary date of the grant.
(9)   Grant to the reporting person of options to buy 2,000 shares of Common Stock exercisable in annual installments of 667, 667 and 666 shares each on May 7, 2003, 2004 and 2005, the anniversary date of the grant.

Page 3